Vrije Universiteit Brussel

 

Publications on Stem Cells

  • No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients.
    Thiel U, Wawer A, Wolf P, Badoglio M, Santucci A, Klingebiel T, Basu O, Borkhardt A, Laws HJ, Kodera Y, Yoshimi A, Peters C, Ladenstein R, Pession A, Prete A, Urban EC, Schwinger W, Bordigoni P, Salmon A, Diaz MA, Afanasyev B, Lisukov I, Morozova E, Toren A, Bielorai B, Korsakas J, Fagioli F, Caselli D, Ehninger G, Gruhn B, Dirksen U, Abdel-Rahman F, Aglietta M, Mastrodicasa E, Torrent M, Corradini P, Demeocq F, Dini G, Dreger P, Eyrich M, Gozdzik J, Guilhot F, Holler E, Koscielniak E, Messina C, Nachbaur D, Sabbatini R, Oldani E, Ottinger H, Ozsahin H, Schots R, Siena S, Stein J, Sufliarska S, Unal A, Ussowicz M, Schneider P, Woessmann W, Jürgens H, Bregni M, Burdach S; Solid Tumor Working Party (STWP) and the Pediatric DiseaseWorking Party (PDWP) of the European Group for Blood and Marrow Transplantation (EBMT); Asia Pacific Blood and Marrow Transplantation (APBMT); Pediatric Registry for Stem Cell Transplantations (PRST); MetaEICESS Study Group. .
    Ann Oncol. 2011 Jul;22(7):1614-21. Epub 2011 Jan 18. 2011

  • Tumor-promoting properties of bone marrow-derived mesenchymal stem cells (MSCs) in multiple myeloma (MM): a potential risk for MSC-based cytotherapy in MM patients?
    Xu S, Menu E, De Becker A, Van Camp B, Vanderkerken K, Van Riet I .
    Stem Cells, accepted 2011 2011

  • HLA-G Expression in Human Embryonic Stem Cells and Preimplantation Embryos.
    Verloes A, Van De Velde H, Lemaoult J, Mateizel I, Cauffman G, Horn PA., Carosella ED, Devroey P, De Waele M, Rebmann V, Vercammen M. .
    Journal of Immunology, 186 (4): 2663-71, 2011. 2011

  • The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.
    Rizzo R, Vercammen M, Van De Velde H, Horn PA., Rebmann V. .
    Cellular and Molecular Life Sciences, 68(3): 341-52, 2011. 2011

  • Restoration of tumor equilibrium after immunotherapy for advanced melanoma: three illustrative cases.
    S. Wilgenhof, L. Pierret, J.Corthals, AM Van Nuffel, C. Heirman, T. Roelandt, A. De Coninck, G. Verfaillie, F. Vandenbroucke, I. Van Riet, A. Bonehill, K. Thielemans, B. Neyns. .
    Melanoma Res, 21(2):152-9, 2011 [Epub ahead of print]. (IF = 2.061) 2011

  • Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma.
    S. Wilgenhof, AM Van Nuffel, J.Corthals, C. Heirman, S. Tiyaerts, D. Benteyn, A. De Coninck, I. Van Riet, G. Verfaillie, J. Vandeloo, A. Bonehill, K. Thielemans, B. Neyns. .
    J. Immunother. 34(5):448-56, 2011.(IF = 3.203) 2011

  • JACIE accreditation: demonstrating high quality of clinical and laboratory practice in stem cell transplantation centers
    I. Van Riet .
    Belgian Journal of Hematology, 2 (1): 10-4, 2011. 2011

  • Effect of sample dilution on serum free light chain concentration by immunonephelometric assay.
    Vercammen M, Meirlaen P, Broodtaerts L, Vande Broek I, Bossuyt X .
    Clinica Chimica Acta 412(19-20): 1798-1804, 2011. 2011

  • 0
    Raymaekers M, Bakkus M, Boone E, De Rijke B, El Housni H, Descheemaeker P, Deschouwer P, Franke S, Hillen F, Nollet F, Soetens O, Vankeerberghen A. .
    Acta Clinica Belgica, 66(1): 33-41, 2011 2011

  • Use of alemtuzumab in B-cell chronic lymphocytic leukaemia: Belgian recommendations.
    Bron D, Janssens A., Vande Broek I, Chatelain C, De Prijck B, Vrelust I, Van Hende V, Van Hoof A, Van Den Neste E. .
    Belgian Journal of Hematology, 2(2): 64-9, 2011. 2011

  • Circulating heat shock protein 70 (Hsp70) in elderly members of a rural population from Cameroon: Association with infection and nutrition.
    Njemini R, Smitz J, Demanet C, Sosso M, Mets T. .
    Arch Gerontol Geriatr, 53(3):359-63, 2011 2011

  • Low CD4+ T Cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.
    Jennes W, Verheyden S, Demanet C, Menten J, Vuylsteke B, Nkengasong J, Kestens L .
    PLoS One. 6(2):e17043., 2011 2011

  • Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.
    Delforge M, Selleslag D, Triffet A, Mineur P, Bries G, Graux C, Trullemans F, Macdonald K, Abraham I, Pluymers W., Ravoet C. .
    Ann Hematol., 90(6): 655-66, 2011. 2011

  • Circulating Heat Shock Protein 70 in Health, Aging and Disease.
    Njemini R, Bautmans I, Onyema O, Van Puyvelde K, Demanet C, Mets T. .
    BMC Immunology, issue 24, vol.12, 2011 2011

  • Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.
    Gorin NC, Labopin M, Reiffers J, Milpied N, Blaise D, Witz F, de Witte T, Meloni G, Attal M, Bernal T, Rocha V; Acute Leukemia Working Party, European Cooperative Group for Blood and Marrow Transplantation. (Schattenberg A, Foa R, Maertens J, Rio B, Torres Gomez A, Harousseau JL, Cahn JY, Deconinck E, Michallet M, Delmer A, Alessandrino EP, Caillot D, Gratecos N, Ifrah N, Lioure B, Bordessoule D, Pogliani EM, Buzyn A, Bunjes D, Bay JO, De Blasio A, Indrák K, Iacopino P, Janssen JJ, Arcese W, Drenou B, Falda M, Iriondo Atienza A, Guilhot F, Lamy T, Schaafsma MR, Milone G, Guyotat D, Bosi A, Feremans W, Berthou C, Rodeghiero F, Levis A, Fremiotti A, Willemze R, Rizzoli V, Colombat P, Dreyfus F, Marianska B, Ljungman P, Ferrant A, Petersen E, Jouet JP, Cortelazzo S, Scimč R, Aljurf M, Bello López JL, Unal A, Caballero D, Rotoli B, Schubert J, Cantore N, Cornelissen JJ, Solano C, Martinelli G, Sánchez de Toledo Codina J, Wijermans PW, Masszi T, Lasa Isasti R, Gallamini A, Zander AR, Schots R, Musso M, Metzner B, Botelho Sousa A, Apperley J, Schanz U, Carreras E, Bron D, Remes K, Di Bartolomeo P, Sierra J, Vernant JP, Zoumbos NC, Moicean A, Zuffa E, Aglietta M, Saglio G, Gutierrez Martín M, Gordon-Smith E, Pérez Equiza E, Urban C, Mistrik M, Gurman G, Wandt H, Afanasyev B, Fernández MN, Edwards D, Malm C, Duarte Palomino RF, Zambelli A, Vivancos P, Leoni P, Diez-Martin JL, Wiktor-Jedrzejczak W.) .
    Blood. 2010 Oct 28;116(17):3157-62. Epub 2010 May 17. 2010

  • An improved harvest and in vitro expansion protocol for murine bone marrow-derived mesenchymal stem cells
    Xu S, De Becker A, Van Camp B, Vanderkerken K, Van Riet I. .
    Journal of Biomedicine and Biotechnology 2010; 2010:105940. Epub 2010 Dec 20. (IF = 1.750) 2010

  • Mouse spermatogonial stem cells obtain morphologic and functional characteristics of hematopoietic cells in vivo.
    Ning L, Goossens E, Geens M, Van Saen D, Van Riet I, He D, Tournaye H. .
    Human Reprod 25(12):3101-9, 2010 [Epub 2010 Oct 11] (IF = 3.869) 2010

  • Use of the Cell-Dyn Sapphire hematology analyzer for automated counting of blood cells in body fluids.
    De Smet D, Van Moer G, Martens G, Nanos N, Smet L, Jochmans K, De Waele M. .
    Am J Clin Pathol., 133(2): 291-9, 2010. 2010

  • Use of likelihood ratios improves interpretation of laboratory testing for pulmonary sarcoidosis.
    De Smet D, Martens G, Vanden Berghe B, Meysman M, Heylen O, Gorus F, De Waele M. .
    Am J Clin Pathol., 134(6): 939-47, 2010. 2010

  • A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology.
    Cazenave JP, Folléa G, Bardiaux L, Boiron JM, Lafeuillade B, Debost M, Lioure B, Harousseau JL, Deconinck E, Tabrizi R, Cahn JY, Michallet M, Ambruso D, Schots R, Tissot JD, Sensebé L, Kondo T, McCullough J, Rebulla P, Escolar G, Mintz P., Heddle NM, Goodrich RP, Bruhwyler J, Le C., Cook RJ, Stouch B. .
    Transfusion, 50(11) : 2362-75, 2010. 2010

  • Hemorrhagic regression of melanoma metastases during therapeutic vaccination: a report of three cases.
    Pierret L, Van Baren N, Bonehill A, Corthals J, Van Nuffel AM, Heirman C, Roelandt T, De Coninck A, Van Riet I, Degreef E, Goossens A, Verfaillie G, Roseeuw D, Thielemans K, Neyns B. .
    Melanoma Res. 19(6): 385-90, 2009. [Epub 2009 Aug 24] (IF = 2.336) 2009

  • Can soluble human leucocyte antigen-G predict successful pregnancy in assisted reproductive technology?
    Vercammen M, Verloes A, Haentjens P, Van De Velde H .
    Current Opinion in Obstetrics & Gynecology, 21(3): 285-90, 2009 2009

  • Implementatie van Europese kwaliteitsnormen (JACIE) voor stamcel-transplantatieprogramma's in België.
    Van Riet I. .
    Onco, 3 (4): 123-7, 2009. 2009

  • Fatal cerebral zygomycosis breakthrough in a patient with acute lymphoblastic leukemia on voriconazole prophylaxis after cord blood SCT.
    Vande Broek I, Schots R. .
    Bone Marrow Transplant. 44(11): 765-6, 2009. 2009

  • Automated validation of clinical laboratory test results: do we get what we expect?
    De Smet D, Nanos N., Martens G, Smet L, Damiaens S, Van Moer G, De Pauw A, Jochmans K, De Waele M. .
    Clin Chem Lab Med., 47(3): 379-80, 2009. 2009

  • Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients.
    Hilbrands R, Huurman VAL, Gillard P, Velthuis J, De Waele M, Mathieu C, Kaufman L, Marichal M, Ling Z, Movahedi B, Jacobs-Tulleneers-Thevissen D, Monbaliu D, Ysebaert D, Gorus F, Roep B, Pipeleers D, Keymeulen B. .
    Diabetes, 58(10): 2267-76, 2009. 2009

  • Tyrosine kinase inhibitor-induced macrocytosis.
    Schallier D, Trullemans F, Fontaine C, Decoster L, De Greve J. .
    Anticancer Res., 29(12) : 5225-8, 2009. 2009

  • Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by natural killer cells.
    Verheyden S, Ferrone S, Mulder A, Claas F, Schots H, De Moerloose B, Benoit Y, Demanet C. .
    Cancer Immunology Immunotherapy, 58(6): 855-65, 2009. 2009

  • Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically
    Mateizel I, Spits C, Verloes A, Mertzanidou A, Liebaers I, Sermon K. .
    Human Reproduction, 24(10): 2477-89, 2009. 2009

  • Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders.
    Vermeersch P, Vercammen M, Holvoet A, Vande Broek I, Delforge M., Bossuyt X. .
    Clinical Chimica Acta, 410(1-2): 54-8, 2009. 2009

  • Guidelines for an integrated diagnostic approach of chronic lymphoproliferative disorders in the routine laboratory of Haematology Belgium.
    Philippe J, Nollet F, Bakkus M, Meeus P, Demanet C, Schaaf-Lafontaine N, Franke S, Chatelain B, Vermeulen K, Boone E, El Housni H, Heimann P, Husson B, Lambert ., Van Nuffel P, Saussoy P, Maes B., Deschouwer P. .
    Acta Clinica Belgica 64(6): 494- 505, 2009. 2009

  • Markers of inflammation in patients with symptomatic and asymptomatic carotid artery stenosis: a case-control study
    Debing E, Peeters E, Demanet C, De Waele M, Van Den Brande P. .
    Vascular and Endovascular Surgery, 2(42): 122-7, 2008 2008

  • Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D-luciferin: effect on intensity, time kinetics and repeatability of photon emission.
    Keyaerts M, Verschueren J, Bos T, Tchouate-Gaicam LO, Peleman C, Breckpot K, Van Hove C, Caveliers V, Bossuyt A, Lahoutte T. .
    Eur J Nucl Med Mol Imaging, 35(5): 999-1007, 2008 2008

  • Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis
    Vercammen M, Verloes A., Van De Velde H, Haentjens P .
    Human Reproduction Update, 14(3): 209-18, 2008. 2008

  • NK cell receptors and their ligands in leukemia
    Verheyden S, Demanet C .
    Leukemia, 22(2): 249-57, 2008. 2008

  • Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA
    Bonehill A, Tuyaerts S, Van Nuffel A, Heirman C, Bos T, Fostier K, Neyns B, Thielemans K .
    Molecular Therapy, 16(6) 1170-80, 2008 2008

  • Aging-related differences in basal heat shock protein 70 levels in lymphocytes are linked to altered frequencies of lymphocyte subsets.
    Njemini R, Demanet C, Mets T. .
    Aging Cell, 7(4): 498-505, 2008. 2008

  • Development of trombotic thrombocytopenic purpura after a single dose of gemcitabine
    De Smet D, Jochmans K, Neyns B. .
    Annals of Hematology, 87(6): 495-6, 2008. 2008

  • Diagnostic accuracy of the triage D-dimer test for exclusion of venous thromboembolism in outpatients
    Ghys T, Achtergael W, Verschraegen I, Leus B, Jochmans K. .
    Thrombosis Research, 121(6): 735-41, 2008. 2008

  • Association of KIR2DS4 and its variant KIR1D with leukemia
    Verheyden S, Demanet C .
    Leukemia, 22: 2129-30, 2008. 2008

  • Guidelines for the use of fresh frozen plasma
    De Backer D, Van De Kerckhove B, Stanworth S, Jochmans K, Williamson L, Hermans C, Van Der Linden P, Hubner R, Baele G, Ferrant A, Lambermont M, Muylle L, Toungouz M. .
    Acta Clinica Belgica, 63: 63-6, 2008 2008

  • Generation of large numbers of dendritic cells in a closed system using Cell Factories.
    Tuyaerts S, Noppe SM, Corthals J, Breckpot K, Heirman C, De Greef C, Van Riet I, Thielemans K .
    J. Immunol. Methods, 264 (1-2): 135-151, 2002. (IF = 2.598) 2002

  • Efficient differentiation of human embryonic stem cells into a homogeneous population of osteoprogenitor-like cells.
    Mateizel I, De Becker A, Van de Velde H, De Rycke M, Van Steirteghem A, Cornelissen R, Van der Elst J, Liebaers I, Van Riet I, Sermon K.
    Reprod Biomed Online 16 (5), 741-53, 2008.
    Abstract.

  • Evaluation of out-of-specification CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products.
    Braakman E, Schuurhuis GJ, Preijers FW, Voermans C, Theunissen K, Van Riet I, Fibbe WE, Slaper-Cortenbach I.
    Cytotherapy 10 (1), 83-9, 2008.
    Abstract.

  • Migration of culture-expanded human mesenchymal stem cells (MSC) through bone marrow endothelium is regulated by matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-3 (TIMP-3).
    De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Wever J, De Waele M, Van Riet I.
    Haematologica 92 (4), 440-9, 2007.
    Abstract.

  • In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease.
    Caveliers V, De Keulenaer G, Everaert H, Van Riet I, Van Camp G, Verheye S, Roland J, Schoors D, Franken PR, Schots R.
    Q J Nucl Med Mol Imaging 51 (1), 61-6, 2007.
    Abstract.

  • Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow.
    Snykers S, Vanhaecke T, De Becker A, Papeleu P, Vinken M, Van Riet I, Rogiers V.
    BMC Dev Biol 7, 24, 2007.
    Abstract.

  • In vitro multipotency of human bone marrow (mesenchymal) stem cells.
    Snykers S, Vanhaecke T, Papeleu P, Henkens T, Vinken M, Elaut G, Van Riet I, Rogiers V.
    ALTEX 23, 400-5, 2007.
    Abstract.

  • Evidence that intracoronary-injected CD133(+) peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.
    Schots R, De Keulenaer G, Schoors D, Caveliers V, Dujardin M, Verheye S, Van Camp G, Franken PR, Roland J, Van Riet I, Everaert H.
    Exp Hematol 35 (12), 1884-90, 2007.
    Abstract.

  • Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms.
    Segers VFM, Van Riet I, Andries LJ, Lemmens K, Demolder MJ, De Becker AJML, Kockx MM, De Keulenaer GW.
    Am J Physiol Heart Circ Physiol 290 (4), H1370-1377, 2006.
    Abstract.

  • A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
    Verheyden S, Schots R, Duquet W, Demanet C.
    Leukemia 19 (8), 1446-1451, 2005.
    Abstract.

  • Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up.
    Orlando G, Ferrant A, Schots R, Goffette P, Mathijs J, Lemaire J, Danse E, Talpe S, Latinne D, Lerut J.
    Transpl Int 18 (1), 125-129 (Review), 2005.
    Abstract.

  • Growth factor receptor profile of CD34 cells in normal bone marrow, cord blood and mobilized peripheral blood.
    De Waele M, Renmans W, Asosingh K, Vander Gucht K, Van Riet I.
    Eur J Haematol 72 (3), 193-202, 2004.
    Abstract.

  • Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.
    Schots R, Kaufman L, Van Riet I, Ben Othman T, De Waele M, Van Camp B, Demanet C.
    Leukemia 17 (6), 1150-1156, 2003.
    Abstract.

  • An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation.
    Schots R, Van Riet I, Othman TB, Trullemans F, De Waele M, Van Camp B, Kaufman L.
    Bone Marrow Transplant 30 (7), 441-446, 2002.
    Abstract.

  • Ethical considerations on preimplantation genetic diagnosis for HLA typing to match a future child as a donor of haematopoietic stem cells to a sibling.
    Pennings G, Schots R, Liebaers I.
    Hum Reprod 17 (3), 534-538 (Review), 2002.
    Abstract.

  • The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R, Van Riet I, Ben Othman T, Trullemans F, De Waele M, Van Camp B.
    Bone Marrow Transplant 28 (10), 917-922, 2001.
    Abstract.

  • Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.
    Trullemans F, Grignard F, Van Camp B, Schots R.
    Eur J Haematol 67 (2), 94-99, 2001.
    Abstract.

  • Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts.
    De Waele M, Renmans W, Vander Gucht K, Jochmans K, Schots R, Otten J, Trullemans F, Lacor P, Van Riet I.
    Eur J Haematol 66 (3), 178-187, 2001.
    Abstract.

  • The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogeneic bone marrow transplantation.
    Schots R, Trullemans F, Van Riet I, Kaufman L, Hafsia A, Meddeb B, Hadj Ali ZB, Ben Abid H, Lauwers S, Van Camp B.
    Transplantation 69 (7), 1511-1514, 2000.
    Abstract.

  • Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts.
    De Waele M, Renmans W, Jochmans K, Schots R, Lacor P, Trullemans F, Otten J, Balduck N, Vander Gucht K, Van Camp B, Van Riet I.
    Eur J Haematol 63 (3), 192-201, 1999.
    Abstract.

  • Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial.
    Facon T, Harousseau JL, Maloisel F, Attal M, Odriozola J, Alegre A, Schroyens W, Hulin C, Schots R, Marin P, Guilhot F, Granena A, De Waele M, Pigneux A, Meresse V, Clark P, Reiffers J.
    Blood 94 (4), 1218-1225, 1999.
    Abstract.

  • The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.
    Dresse MF, Boogaerts M, Vermylen C, Noens L, Ferrant A, Schots R, Doyen C, Bron D, Berneman Z, Ferster A, Benoit Y, Demuynck H, Beguin Y.
    Haematologica 84 (7), 637-642, 1999.
    Abstract.

  • Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
    Schots R, Kaufman L, Van Riet I, Lacor P, Trullemans F, De Waele M, Van Camp B.
    Bone Marrow Transplant 22 (1), 79-85, 1998.
    Abstract.

  • Circulating CD34+ cells in cord blood and mobilized blood have a different profile of adhesion molecules than bone marrow CD34+ cells.
    Asosingh K, Renmans W, Van der Gucht K, Foulon W, Schots R, Van Riet I, De Waele M.
    Eur J Haematol 60 (3), 153-160, 1998.
    Abstract.

  • Different expression of adhesion molecules on myeloid and B-lymphoid CD34+ progenitors in normal bone marrow.
    De Waele M, Renmans W, Damiaens S, Flament J, Schots R, Van Riet I.
    Eur J Haematol 59 (5), 277-286, 1997.
    Abstract.

  • Persistence of residual tumour cells after cytokine-mediated ex vivo expansion of mobilized CD34+ blood cells in multiple myeloma.
    Van Riet I, Juge-Morineau N, Schots R, De Waele M, De Greef C, Thielemans K, Van Camp B, Bakkus M.
    Br J Haematol 96 (2), 403-411, 1997.
    Abstract.

  • The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
    Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y, Steenssens L, van Camp B, De Waele M.
    Bone Marrow Transplant 17 (4), 509-515, 1996.
    Abstract.

  • Experience with high dose chemotherapy and autologous bone marrow transplantation in testicular cancer.
    Schots R, Storme G.
    J Belge Radiol 76 (2), 98-99 (Review), 1993.
    Abstract.

  • Peripheral blood stem cell transplantation.
    Schots R, Van Camp B.
    Acta Clin Belg 48 (6), 363-370, 1993.

  • Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Reynaert H, De Coninck A, Neven AM, Van Camp B, Schots R.
    Bone Marrow Transplant 10 (2), 185-187, 1992.
    Abstract.

  • Immunomagnetic purging of bone marrow grafts for autologous transplantation in neuroblastoma.
    Van Riet I, Schots R, Balduc N, Van den Brande G, Sariban E, Otten J, Van Camp B.
    Acta Clin Belg 45 (2), 97-106, 1990.
    Abstract.

 

Back to top

  ©2004-2006 • HEIM • Vrije Universiteit Brussel • Faculteit Geneeskunde & Farmacie • Laarbeeklaan 103 • 1090 Jette • Tel.: (+32)-(0)2-477.44.06 • heim@vub.ac.be